Sign in
AERI Stock Price, Chart, Stats & News
Aerie Pharmaceuticals, Inc.
Save
–
Market cap
–
Current P/E
–
Forward P/E
AERI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 86.17% |
Operating margin | -23.34% |
Pretax margin | -38.23% |
Net margin | -38.54% |
Effective tax rate | -0.80% |
ROA | -17.34% |
ROE | -2255.01% |
D/E | -15.04x |
Interest coverage ratio | -1.57x |
AERI valuation
P/E | – |
P/S | – |
P/B | -40.77x |
P/CF | -7.13x |
P/FCF | – |
P/OCF | -7.13x |
PEG | -0.09x |
EV multiple | 33.00x |
About
Aerie Pharmaceuticals, Inc. operates as a pharmaceutical enterprise focused on the discovery, development, and commercialization of ophthalmic treatments for the U. S. market. The company's therapeutic scope includes open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration.
Similar securities
Based on sector and market capitalization
Report issue